Who has invested in Enlaza Therapeutics?

J.P. Morgan Private Capital are named among the investors backing Enlaza Therapeutics.

Enlaza Therapeutics Funding: $161M Raised, Series A (2024)

Enlaza Therapeutics funding overview

Enlaza Therapeutics is a Biotech company based in La Jolla, California. Enlaza Therapeutics has raised $161M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2024. The round record for Enlaza Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include J.P. Morgan Private Capital.

Enlaza Therapeutics at a glance

Total raised: $161M
Latest round: Series A
Latest round date: April 2024
Industry: Biotech
Headquarters: La Jolla, California
Notable investors: J.P. Morgan Private Capital

Frequently asked about Enlaza Therapeutics funding

How much has Enlaza Therapeutics raised?: Enlaza Therapeutics has raised $161M in total disclosed funding across the rounds on record.
Who has invested in Enlaza Therapeutics?: J.P. Morgan Private Capital are named among the investors backing Enlaza Therapeutics.
What was the latest Enlaza Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2024.
Where is Enlaza Therapeutics based?: Enlaza Therapeutics is based in La Jolla, California.
What sector does Enlaza Therapeutics operate in?: Enlaza Therapeutics is tracked under Biotech from La Jolla, California, with $161M in disclosed funding.
When did Enlaza Therapeutics last raise?: The last disclosed Enlaza Therapeutics round closed in April 2024 at Series A.

Enlaza Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in La Jolla below to benchmark round size and investor mix.

Enlaza Therapeutics Funding: $161M Raised, Series A (2024)

Enlaza Therapeutics funding overview

Enlaza Therapeutics at a glance

Frequently asked about Enlaza Therapeutics funding

Enlaza Therapeutics founders (1)

Companies related to Enlaza Therapeutics (29)

Browse related funding lists (3)